oral cal mpk- calcium phosphorus magnesium potassium dextrose solution
durvet, inc. - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), sodium hypophosphite monohydrate (unii: 4vn69wup7n) (hypophosphite ion - unii:238u65nz04), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - calcium cation 9 g in 500 ml - calcium-phosphorus-magnesium-potassium-dextrose oral solution for animal use only keep out of reach of children indications for use as a supplemental nutritive source of calcium, phosphorus, magnesium, potassium and dextrose in cattle.
calcium resonium calcium polystyrene sulfonate powder can
sanofi-aventis australia pty ltd - calcium polystyrene sulfonate, quantity: 999.3 mg/g - powder - excipient ingredients: vanillin; saccharin - calcium resonium is an ion-exchange resin. it is recommended for the treatment of hyperkalaemia associated with anuria and severe oliguria.,it is also used to treat hyperkalaemia in patients requiring dialysis and in patients on regular haemodialysis or on prolonged peritoneal dialysis.
calcium folinate ebewe
novartis new zealand ltd - calcium folinate pentahydrate 12.71 mg/ml equivalent to 10 mg/ml folinic acid - concentrate for injection - 10 mg/ml - active: calcium folinate pentahydrate 12.71 mg/ml equivalent to 10 mg/ml folinic acid excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - · as rescue therapy to reduce toxicity following high-dose methotrexate therapy. · has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions · overdosage of methotrexate and in impaired methotrexate elimination · reducing the toxicity and circumventing the effect of folic acid antagonists
calcium resonium
pharmacy retailing (nz) ltd t/a healthcare logistics - calcium polystyrene sulfonate 99.93% (binding capacity 1.7meq/g); ; - powder for oral solution - 1.7 meq/g - active: calcium polystyrene sulfonate 99.93% (binding capacity 1.7meq/g) excipient: saccharin vanillin
calcium gluconate 10 % injection b.p.
lapidot medical import and marketing ltd - calcium gluconate - solution for injection - calcium gluconate 0.94 g / 10 ml - calcium gluconate - calcium gluconate - treatment of acute symptomatic hypocalcaemia.
calcium chloride injection minijet 10% w/v, solution for injection
international medication systems (uk) ltd - calcium chloride dihydrate - solution for injection - 10 percent weight/volume - calcium; calcium chloride
glucalphos bf
elanco new zealand - calcium saccharate tetrahydrate; calcium chloride dihydrate; dextrose; magnesium hypophosphite; calcium gluconate ( mixture of isomers) - calcium saccharate tetrahydrate 5 g/litre; calcium chloride dihydrate 41.4 g/litre; dextrose 250 g/litre; magnesium hypophosphite 50 g/litre; calcium gluconate ( mixture of isomers) 77.14 g/litre - parenteral nutrient/electrolyte
calcium chloride injection minijet 10% w/v, solution for injection
dlrc pharma services limited - calcium chloride dihydrate - solution for injection - 10 percent weight/volume - calcium; calcium chloride
calcium acetate 500mg tablets
pinewood laboratories ltd - calcium acetate - tablet - 500 milligram(s) - calcium; calcium acetate anhydrous
calcium resonium
sanofi malta limited - calcium polystyrene sulfonate - powder for oral suspension - calcium polystyrene sulfonate 99.934 % (w/w) - mineral supplements